TERT and thyroid cancer: In most somatic cells, telomeres shorten with cell division, and when their length reaches a critical point, cells enter senescence or apoptosis (96).However, in thyroid cancer cells, an activating mutation in the TERT promoter (TERTp) prevents telomere shortening, allowing tumor cells to continue dividing and proliferating (97), thereby driving disease progression.